Yoshimitsu Hirai

Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration

Yuka Aoishi, Shoji Oura, H Nishiguchi et al. · Breast Cancer · 2020 · 41 citations

Breast Oncology, Medicine, Pathology +4

Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non–Small-cell Lung Cancer

Daisuke Noma, Kentaro Inamura, Yosuke Matsuura et al. · Clinical Lung Cancer · 2017 · 39 citations

Non–small-cell Lung Cancer, Lymphoid Neoplasia, Lymphovascular Invasion +7

A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.

Tatsuya Yoshimasu, Takuya Ohashi, Shoji Oura et al. · PubMed · 2015 · 20 citations

Hormetic Reactions, Pathology, Theoretical Model +16

Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer

Tatsuya Yoshimasu, Shoji Oura, Fuminori Ohta et al. · Journal of Thoracic Oncology · 2011 · 16 citations · Full text

Docetaxel Sensitivity, Oncogenic Agent, Medicine +7

In vitro evaluation of dose-response curve for paclitaxel in breast cancer

Tatsuya Yoshimasu, Shoji Oura, Issei Hirai et al. · Breast Cancer · 2007 · 15 citations

Breast Oncology, Oncology, Dose-response Curve +9